Utilization of Intravenous Ribavirin Among Reproductive Age Adults in 2010–2017: A Population-Based Study in the Yinzhou District, Ningbo City of China

Background: Intravenous (IV) ribavirin is not approved in US and European Union, but it is authorized in China. Significant teratogenic and embryocidal effects of ribavirin have been found in almost all animal studies, it is critical to investigate the prevalence and trends of the utilization of IV...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hailong, Zhao, Houyu, Lin, Hongbo, Shen, Peng, Liu, Cuili, Zhan, Siyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484711/
https://www.ncbi.nlm.nih.gov/pubmed/34604152
http://dx.doi.org/10.3389/fpubh.2021.678785

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484711/
https://www.ncbi.nlm.nih.gov/pubmed/34604152
http://dx.doi.org/10.3389/fpubh.2021.678785

Ejemplares similares